{"id":"NCT02074982","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis","officialTitle":"A 52-week, Multicenter, Randomized, Double-blind Study of Subcutaneous Secukinumab to Demonstrate Efficacy as Assessed by Psoriasis Area and Severity Index at 16 Weeks of Treatment Compared to Ustekinumab and to Assess Long-term Safety, Tolerability and Efficacy in Subjects With Moderate to Severe Plaque Psoriasis (CLEAR)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-02-26","primaryCompletion":"2016-06-29","completion":"2016-06-29","firstPosted":"2014-03-03","resultsPosted":"2017-07-21","lastUpdate":"2017-07-21"},"enrollment":676,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Plaque Type Psoriasis"],"interventions":[{"type":"DRUG","name":"AIN457 300 mg","otherNames":["secukinumab"]},{"type":"DRUG","name":"ustekinumab 45/90 mg","otherNames":[]},{"type":"DRUG","name":"placebo secukinumab","otherNames":[]}],"arms":[{"label":"AIN457 300 mg","type":"EXPERIMENTAL"},{"label":"Ustekinumab","type":"ACTIVE_COMPARATOR"}],"summary":"This study assessed efficacy of secukinumab, compared to ustekinumab, in patients that have plaque-type psoriasis","primaryOutcome":{"measure":"Percentage of Participants With Moderate to Severe Plaque Psoriasis Who Achieved Psoriasis Area and Severity Index (PASI) 90 at Week 16","timeFrame":"Week 16","effectByArm":[{"arm":"AIN457 300 mg","deltaMin":79,"sd":null},{"arm":"Ustekinumab","deltaMin":57.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":137,"countries":["United States","Australia","Austria","Belgium","Bulgaria","Canada","Denmark","Estonia","France","Germany","Greece","Hungary","Israel","Italy","Netherlands","Norway","Portugal","Slovakia","South Korea","Spain","Switzerland","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["36334236","35305260","34870789","30972746","26092291"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":41,"n":335},"commonTop":["NASOPHARYNGITIS","HEADACHE","UPPER RESPIRATORY TRACT INFECTION","ARTHRALGIA","BACK PAIN"]}}